Moreover, Li et al. showed that glioblastomas expressing high levels of CD133 are extremely correlated with the expression of HOX gene stem cell factors, a prognostic marker found to be associated with survival and chemotherapeutic resistance. The gene discussed is PROM1; the disease is glioblastoma.